Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function
Immune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in t...
Gespeichert in:
Veröffentlicht in: | Oncoimmunology 2016-05, Vol.5 (5), p.e1122861-e1122861 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1122861 |
---|---|
container_issue | 5 |
container_start_page | e1122861 |
container_title | Oncoimmunology |
container_volume | 5 |
creator | Zhang, Ningyan Jordan, Robert E. An, Zhiqiang |
description | Immune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in the tumor microenvironment. |
doi_str_mv | 10.1080/2162402X.2015.1122861 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_27467920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1807898264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-373239ba6d3d3786af9604a95aa2e50b1b8d0b68b1b8aeb66f77cef34c6eb3763</originalsourceid><addsrcrecordid>eNp9UUtv1DAQthAVrUp_QpGPXHbxI7GdCwJVvKRKXFqpN8txxlujxF5spyj_HofdruCCLx7NfI8ZfQhdU7KlRJF3jArWEPawZYS2W0oZU4K-QBdrf7MOXp5qSs_RVc4_SH2CtIJ3r9A5k42QHSMXKN_NU0wYnkz2MeDo8OPaMCP20zQHXxY8weBNgQH3C96nWCCOS_G2AvbGpwlCWWkmFN_HYcEl-d0OUsX_UQAMzoEt1cTNwZbq8hqdOTNmuDr-l-j-86e7m6-b2-9fvt18vN3YRqiy4ZIz3vVGDHzgUgnjOkEa07XGMGhJT3s1kF6otTDQC-GktOB4YwX0XAp-id4fdPdzX4-wddN6mN4nP5m06Gi8_ncS_KPexSfddJRIwqrA26NAij9nyEVPPlsYRxMgzllTRaTqFBNNhbYHqE0x5wTuZEOJXjPTz5npNTN9zKzy3vy944n1nFAFfDgAfHAxTeZXTOOgi1nGmFwywfqs-f89fgNN56pn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1807898264</pqid></control><display><type>article</type><title>Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function</title><source>PubMed Central</source><creator>Zhang, Ningyan ; Jordan, Robert E. ; An, Zhiqiang</creator><creatorcontrib>Zhang, Ningyan ; Jordan, Robert E. ; An, Zhiqiang</creatorcontrib><description>Immune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in the tumor microenvironment.</description><identifier>ISSN: 2162-4011</identifier><identifier>ISSN: 2162-402X</identifier><identifier>EISSN: 2162-402X</identifier><identifier>DOI: 10.1080/2162402X.2015.1122861</identifier><identifier>PMID: 27467920</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Antibody immunity ; Author's View ; cancer immune evasion ; single proteolytic cleavage of the IgG hinge ; tumor microenvironment</subject><ispartof>Oncoimmunology, 2016-05, Vol.5 (5), p.e1122861-e1122861</ispartof><rights>2016 Taylor & Francis Group, LLC 2016</rights><rights>2016 Taylor & Francis Group, LLC 2016 Taylor & Francis Group, LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-373239ba6d3d3786af9604a95aa2e50b1b8d0b68b1b8aeb66f77cef34c6eb3763</citedby><cites>FETCH-LOGICAL-c468t-373239ba6d3d3786af9604a95aa2e50b1b8d0b68b1b8aeb66f77cef34c6eb3763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910702/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910702/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,729,782,786,887,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27467920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Ningyan</creatorcontrib><creatorcontrib>Jordan, Robert E.</creatorcontrib><creatorcontrib>An, Zhiqiang</creatorcontrib><title>Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function</title><title>Oncoimmunology</title><addtitle>Oncoimmunology</addtitle><description>Immune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in the tumor microenvironment.</description><subject>Antibody immunity</subject><subject>Author's View</subject><subject>cancer immune evasion</subject><subject>single proteolytic cleavage of the IgG hinge</subject><subject>tumor microenvironment</subject><issn>2162-4011</issn><issn>2162-402X</issn><issn>2162-402X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9UUtv1DAQthAVrUp_QpGPXHbxI7GdCwJVvKRKXFqpN8txxlujxF5spyj_HofdruCCLx7NfI8ZfQhdU7KlRJF3jArWEPawZYS2W0oZU4K-QBdrf7MOXp5qSs_RVc4_SH2CtIJ3r9A5k42QHSMXKN_NU0wYnkz2MeDo8OPaMCP20zQHXxY8weBNgQH3C96nWCCOS_G2AvbGpwlCWWkmFN_HYcEl-d0OUsX_UQAMzoEt1cTNwZbq8hqdOTNmuDr-l-j-86e7m6-b2-9fvt18vN3YRqiy4ZIz3vVGDHzgUgnjOkEa07XGMGhJT3s1kF6otTDQC-GktOB4YwX0XAp-id4fdPdzX4-wddN6mN4nP5m06Gi8_ncS_KPexSfddJRIwqrA26NAij9nyEVPPlsYRxMgzllTRaTqFBNNhbYHqE0x5wTuZEOJXjPTz5npNTN9zKzy3vy944n1nFAFfDgAfHAxTeZXTOOgi1nGmFwywfqs-f89fgNN56pn</recordid><startdate>20160503</startdate><enddate>20160503</enddate><creator>Zhang, Ningyan</creator><creator>Jordan, Robert E.</creator><creator>An, Zhiqiang</creator><general>Taylor & Francis</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160503</creationdate><title>Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function</title><author>Zhang, Ningyan ; Jordan, Robert E. ; An, Zhiqiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-373239ba6d3d3786af9604a95aa2e50b1b8d0b68b1b8aeb66f77cef34c6eb3763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antibody immunity</topic><topic>Author's View</topic><topic>cancer immune evasion</topic><topic>single proteolytic cleavage of the IgG hinge</topic><topic>tumor microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Ningyan</creatorcontrib><creatorcontrib>Jordan, Robert E.</creatorcontrib><creatorcontrib>An, Zhiqiang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncoimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Ningyan</au><au>Jordan, Robert E.</au><au>An, Zhiqiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function</atitle><jtitle>Oncoimmunology</jtitle><addtitle>Oncoimmunology</addtitle><date>2016-05-03</date><risdate>2016</risdate><volume>5</volume><issue>5</issue><spage>e1122861</spage><epage>e1122861</epage><pages>e1122861-e1122861</pages><issn>2162-4011</issn><issn>2162-402X</issn><eissn>2162-402X</eissn><abstract>Immune suppression is recognized as a hallmark of cancer and this notion is largely based on studies on cellular immunity. Our recent studies have demonstrated a potential new mechanism of cancer suppression of immunity by impairment of antibody effector function mediated by proteolytic enzymes in the tumor microenvironment.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>27467920</pmid><doi>10.1080/2162402X.2015.1122861</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2162-4011 |
ispartof | Oncoimmunology, 2016-05, Vol.5 (5), p.e1122861-e1122861 |
issn | 2162-4011 2162-402X 2162-402X |
language | eng |
recordid | cdi_pubmed_primary_27467920 |
source | PubMed Central |
subjects | Antibody immunity Author's View cancer immune evasion single proteolytic cleavage of the IgG hinge tumor microenvironment |
title | Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T15%3A50%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20evasion%20of%20humoral%20immunity%20mediated%20by%20proteolytic%20impairment%20of%20antibody%20triggered%20immune%20effector%20function&rft.jtitle=Oncoimmunology&rft.au=Zhang,%20Ningyan&rft.date=2016-05-03&rft.volume=5&rft.issue=5&rft.spage=e1122861&rft.epage=e1122861&rft.pages=e1122861-e1122861&rft.issn=2162-4011&rft.eissn=2162-402X&rft_id=info:doi/10.1080/2162402X.2015.1122861&rft_dat=%3Cproquest_pubme%3E1807898264%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1807898264&rft_id=info:pmid/27467920&rfr_iscdi=true |